Role of green macroalgae Enteromorpha prolifera polyphenols in the modulation of gene expression and intestinal microflora profiles in type 2 diabetic mice

International Journal of Molecular Sciences

Volumn 20, Issue 1, 2019, Pages

  Lin, Guopeng ^a   Liu, Xiaoyan ^b   Yan, Xin ^a   Liu, Dan ^a   Yang, Chengfeng ^b   Liu, Bin ^a   Huang, Yifan ^a   Zhao, Chao ^a,c  

^a FUJIAN AGRICULTURE AND FORESTRY UNIVERSITY   (China)

^b CHINA AGRICULTURAL UNIVERSITY   (China)

^c QUANZHOU NORMAL UNIVERSITY   (China)

Author keywords

Antidiabetic activity; Enteromorpha prolifera; Intestinal microflora; Polyphenols; Signaling pathway

Indexed keywords

ALGAL EXTRACT; ENTEROMORPHA PROLIFERA EXTRACT; JANUS KINASE 1; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL KINASE; POLYPHENOL; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

AKKERMANSIA; ALISTIPES; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; BODY WEIGHT; COMPARATIVE STUDY; CONTROLLED STUDY; ENTEROMORPHA PROLIFERA; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HEPATITIS; HISTOPATHOLOGY; INTESTINE FLORA; LIPID DIET; MACROALGA; MALE; MOUSE; MRNA EXPRESSION LEVEL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; REAL TIME POLYMERASE CHAIN REACTION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TIME OF FLIGHT MASS SPECTROMETRY; TURICIBACTER; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; WESTERN BLOTTING; ANIMAL; CHEMISTRY; DIET RESTRICTION; DISEASE MODEL; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; GLUCOSE TOLERANCE TEST; GREEN ALGA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIVER; METABOLISM; PATHOLOGY; SEAWEED; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY;

ANIMALS; BLOOD GLUCOSE; CHLOROPHYTA; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; FASTING; GASTROINTESTINAL MICROBIOME; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GLUCOSE TOLERANCE TEST; LIVER; MICE; POLYPHENOLS; SEAWEED; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY;

EID: 85058923794     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms20010025     Document Type: Article

References (25)

1. Zheng, Y.; Ley, S.H.; Hu, F.B. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat. Rev. Endocrinol. 2018, 14, 88–98. [CrossRef] [PubMed]
2. Zhao, C.; Wu, Y.; Yang, C.; Liu, B.; Huang, Y. Hypotensive, hypoglycaemic and hypolipidaemic effects of bioactive compounds from microalgae and marine micro-organisms. Int. J. Food Sci. Technol. 2015, 50, 1705–1717. [CrossRef]
3. Brunkwall, L.; Orho-Melander, M. The gut microbiome as a target for prevention and treatment of hyperglycaemia in type 2 diabetes: From current human evidence to future possibilities. Diabetologia 2017, 60, 943–951. [CrossRef] [PubMed]
4. Zhao, C.; Yang, C.F.; Liu, B.; Lin, L.; Sarker, S.D.; Nahar, L.; Yu, H.; Cao, H.; Xiao, J. Bioactive compounds from marine macroalgae and their hypoglycemic benefits. Trends Food Sci. Technol. 2018, 72, 1–12. [CrossRef]
5. Fernando, I.P.; Kim, M.; Son, K.T.; Jeong, Y.; Jeon, Y.J. Antioxidant activity of marine algal polyphenolic compounds: A mechanistic approach. J. Med. Food 2016, 19, 615–628. [CrossRef]
6. Murray, M.; Dordevic, A.L.; Bonham, M.P.; Ryan, L. Do marine algal polyphenols have antidiabetic, anti-hyperlipidaemic or anti-inflammatory effects in humans? A systematic review. Crit. Rev. Food Sci. Nutr. 2018, 58, 2039–2054. [CrossRef]
7. Moussavou, G.; Kwak, D.H.; Obiang-Obonou, B.W.; Maranguy, C.A.; Dinzouna-Boutamba, S.D.; Lee, D.H.; Pissibanganga, O.G.; Ko, K.; Seo, J.I.; Choo, Y.K. Anticancer effects of different seaweeds on human colon and breast cancers. Mar. Drugs 2014, 12, 4898–4911. [CrossRef]
8. Athukorala, Y.; Lee, K.W.; Kim, S.K.; Jeon, Y.J. Anticoagulant activity of marine green and brown algae collected from Jeju Island in Korea. Bioresour. Technol. 2007, 98, 1711–1716. [CrossRef]
9. Charoensiddhi, S.; Conlon, M.A.; Franco, C.M.M.; Zhang, W. The development of seaweed-derived bioactive compounds for use as prebiotics and nutraceuticals using enzyme technologies. Trends Food Sci. Technol. 2017, 70, 20–33. [CrossRef]
10. Hardouin, K.; Bedoux, G.; Burlot, A.S.; Donnay-Moreno, C.; Bergé, J.P.; Nyvall-Collén, P.; Bourgougnon, N. Enzyme-assisted extraction (EAE) for the production of antiviral and antioxidant extracts from the green seaweed Ulva armoricana (Ulvales, Ulvophyceae). Algal Res. 2016, 16, 233–239. [CrossRef]
11. Abu-Farha, M.; Cherian, P.; Al-Khairi, I.; Tiss, A.; Khadir, A.; Kavalakatt, S.; Warsame, S.; Dehbi, M.; Behbehani, K.; Abubaker, J. DNAJB3/HSP-40 cochaperone improves insulin signaling and enhances glucose uptake in vitro through JNK repression. Sci. Rep. 2015, 5, 1–12. [CrossRef] [PubMed]
12. Gaster, M.; Staehr, P.; Beck-Nielsen, H.; Schroder, H.D.; Handberg, A. GLUT4 is reduced in slow muscle fibers of type 2 diabetic patients: Is insulin resistance in type 2 diabetes a slow, type 1 fiber disease? Diabetes 2001, 50, 1324–1329. [CrossRef] [PubMed]
13. Wang, Y.; Nishina, P.M.; Naggert, J.K. Degradation of IRS1 leads to impaired glucose uptake in adipose tissue of the type 2 diabetes mouse model TALLYHO/Jng. J. Endocrinol. 2009, 203, 65–74. [CrossRef] [PubMed]
14. Cordero-Herrera, I.; Martín, M.A.; Bravo, L.; Goya, L.; Ramos, S. Cocoa flavonoids improve insulin signalling and modulate glucose production via Akt and AMPK in HepG2 cells. Mol. Nutr. Food Res. 2013, 57, 974–985. [CrossRef] [PubMed]
15. Cui, J.; Zhang, M.; Zhang, Y.Q.; Xu, Z.H. JNK pathway: Diseases and therapeutic potential. Acta Pharmacol. Sin. 2007, 28, 601–608. [CrossRef] [PubMed]
16. Yan, X.; Yang, C.F.; Lin, G.P.; Chen, Y.Q.; Miao, S.; Liu, B.; Zhao, C. Antidiabetic potential of green seaweed Enteromorpha prolifera flavonoids regulating insulin signaling pathway and gut microbiota in type 2 diabetic mice. J. Food Sci. 2018. [CrossRef]
17. Sharma, B.R.; Karki, R.; Lee, E.; Zhu, Q.; Gurung, P.; Kanneganti, T.D. Innate immune adaptor MyD88 deficiency prevents skin inflammation in SHARPIN-deficient mice. Cell Death Differ. 2018. [CrossRef] [PubMed]
18. Zhao, C.; Yang, C.F.; Chen, M.J.; Lv, X.C.; Liu, B.; Yi, L.Z.; Cornara, L.; Wei, M.C.; Yang, Y.C.; Tundis, R.; et al. Regulatory efficacy of brown seaweed Lessonia nigrescens extract on the gene expression profile and intestinal microflora in type 2 diabetic mice. Mol. Nutr. Food Res. 2018, 62, 1700730. [CrossRef]
19. Huo, J.H.; Du, X.W.; Sun, G.D.; Dong, W.T.; Wang, W.M. Identification and characterization of major constituents in Juglans mandshurica using ultra performance liquid chromatography coupled with time-of-flight mass spectrometry (UPLC-ESI-Q-TOF/MS). Chin. J. Nat. Med. 2018, 16, 525–545. [CrossRef]
20. Zeng, X.; Su, W.; Zheng, Y.; Liu, H.; Li, P.; Zhang, W.; Liang, Y.; Bai, Y.; Peng, W.; Yao, H. UFLC-Q-TOF-MS/MS-Based screening and identification of flavonoids and derived metabolites in human urine after oral administration of exocarpium Citri Grandis extract. Molecules 2018, 23, 895. [CrossRef]
21. Sharma, B.R.; Kim, H.J.; Rhyu, D.Y. Caulerpa lentillifera extract ameliorates insulin resistance and regulates glucose metabolism in C57BL/KsJ-db/db mice via PI3K/Akt signaling pathway in myocytes. J. Transl. Med. 2015, 13, 62. [CrossRef]
22. Shang, Q.; Shi, J.; Song, G.; Zhang, M.; Cai, C.; Hao, J.; Li, G.; Yu, G. Structural modulation of gut microbiota by chondroitin sulfate and its oligosaccharide. Int. J. Biol. Macromol. 2016, 89, 489–498. [CrossRef] [PubMed]
23. Dias, M.F.; Reis, M.P.; Acurcio, L.B.; Carmo, A.O.; Diamantino, C.F.; Motta, A.M.; Kalapothakis, E.; Nicoli, J.R.; Nascimento, A.M.A. Changes in mouse gut bacterial community in response to different types of drinking water. Water Res. 2018, 132, 79–89. [CrossRef] [PubMed]
24. Mardinoglu, A.; Boren, J.; Smith, U. Confounding effects of metformin on the human gut microbiome in type 2 diabetes. Cell Metab. 2016, 23, 10–12. [CrossRef] [PubMed]
25. Larsen, N.; Vogensen, F.K.; Van Den Berg, F.W.J.; Nielsen, D.S.; Andreasen, A.S.; Pedersen, B.K.; Al-Soud, W.A.; Sørensen, S.J.; Hansen, L.H.; Jakobsen, M. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS ONE 2010, 5, e9085. [CrossRef]